Discover 1,436 paid clinical trials in Renton, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,436
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
for
Clear Cell Renal Cell Carcinoma
Location: Seattle WA, Sacramento CA, Duarte CA, Phoenix AZ,
Sponsor: Xencor, Inc.
Sex: All
Age: 18+
Code: NCT05433142
Phase1, Recruiting
Evaluation of Dupilumab in Patients With Atopic Keratoconjunctivitis (AKC)
for
Atopic Keratoconjunctivitis
Location: Seattle WA, Los Angeles CA, Littleton CO, Fargo ND,
Sponsor: Andover Eye Associates
Sex: All
Age: 18+
Code: NCT04296864
Phase2, Recruiting
A Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Oral Rilzabrutinib Compared With Placebo in Participants 18 Years of Age and Older With Warm Autoimmune Hemolytic Anemia
for
Autoimmune Haemolytic Anaemia
Location: Seattle WA, Stanford CA, Duarte CA, Los Angeles CA,
Sponsor: Sanofi
Sex: All
Age: 18+
Code: NCT07086976
Phase3, Recruiting
A Study of Belumosudil in Children With Chronic Graft Versus Host Disease (schoolROCK)
for
Chronic Graft Versus Host Disease
Location: Seattle WA, Vancouver, Los Angeles CA, Houston TX,
Sponsor: Sanofi
Sex: All
Age: 1 - 18
Code: NCT07116031
Phase2, Recruiting
A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
for
Locally Advanced or Metastatic Solid Tumors, Colorectal Cancer,
Location: Seattle WA, San Francisco CA, Los Angeles CA, Aurora CO,
Sponsor: ArriVent BioPharma, Inc.
Sex: All
Age: 18+
Code: NCT07066657
Phase1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Real-world Chronic Myelogenous Leukemia (CML) Patient Disease Registry to Describe Patient Experience and Clinical Outcomes Among Patients With CML Receiving Approved First or Second Line Tyrosine Kinase Inhibitor (TKI) Therapy
for
Chronic Myelogenous Leukemia - Chronic Phase
Location: Seattle WA, Tacoma WA, Salem OR, Stockton CA,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT07091019
Recruiting
Venetoclax and Lintuzumab-Ac225 in AML Patients
for
Acute Myeloid Leukemia, Relapsed Adult AML
Location: Seattle WA, Los Angeles CA, Louisville KY,
Sponsor: Actinium Pharmaceuticals
Sex: All
Age: 18+
Code: NCT03867682
Phase1, Phase2, Recruiting
A Study of EP0031 (Lunbotinib) in Patients With Advanced RET-altered Malignancies
for
NSCLC
Location: Seattle WA, Portland OR, Stanford CA, Los Angeles CA,
Sponsor: Ellipses Pharma
Sex: All
Age: 18+
Code: NCT05443126
Phase1, Phase2, Recruiting
A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies